Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
142M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
31.4M
-
Shares change
-
+4.63M
-
Total reported value, excl. options
-
$487M
-
Value change
-
+$66M
-
Number of buys
-
48
-
Number of sells
-
-23
-
Price
-
$15.53
Significant Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) as of Q1 2021
85 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2021.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
of 142M outstanding shares and own 22.13% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4.95M shares), WELLINGTON MANAGEMENT GROUP LLP (3.79M shares), Logos Global Management LP (3.2M shares), CITADEL ADVISORS LLC (3.1M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), BlackRock Inc. (1.24M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (1M shares), FRANKLIN RESOURCES INC (931K shares), VANGUARD GROUP INC (874K shares), and JANUS HENDERSON GROUP PLC (864K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.